Crystalline forms of (9r, 135s)-13- {4-[5-chloro-2-(4-chloro-1h,2,3- triazol- 1 -yl)phenyl] -6-oxo- 1,6-dihydropyrimidin- 1-yl}-3-(difluoromethyl)-9-methyl-3,4,7,15- tetraazatricyclo [ 12.3.1.02·6] octadeca- 1(18), 2(6), 4, 14, 16-pentaen-8-one

Crystalline forms of (9r, 135s)-13- {4-[5-chloro-2-(4-chloro-1h,2,3- triazol- 1 -yl)phenyl] -6-oxo- 1,6-dihydropyrimidin- 1-yl}-3-(difluoromethyl)-9-methyl-3,4,7,15- tetraazatricyclo [ 12.3.1.02·6] octadeca- 1(18), 2(6), 4, 14, 16-pentaen-8-one

Disclosed are crystalline forms of Compound (I). Compound (I) is useful as an anti-thromboembolic agent in the treatment of cardiovascular diseases.

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: XIOURAS Christos, SMITH Daniel, GALELLA Michael A, DILGER Andrew K, L?DEKER David, ZIEMBA Theresa M, AHUJA Dipali, CLEEREN Dirk Angelina J
Format: Patent
Sprache:eng ; heb
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator XIOURAS Christos
SMITH Daniel
GALELLA Michael A
DILGER Andrew K
L?DEKER David
ZIEMBA Theresa M
AHUJA Dipali
CLEEREN Dirk Angelina J
description Disclosed are crystalline forms of Compound (I). Compound (I) is useful as an anti-thromboembolic agent in the treatment of cardiovascular diseases.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_IL297206A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>IL297206A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_IL297206A3</originalsourceid><addsrcrecordid>eNqFT8FKxDAQ3YsHUX9B5thCpmySNrs9yqIoePS2LEtopzSQJiWNYFb8Lu_-k3cj6tnDzDweb97jna8-dyEtUVtrHMHgw7SAH6BoAwMum6VELhFea9w32I3WB48Ci_oP85EJlgUxGH3yFoEDJlvOI7lkD4AK_YvPLFPYmzH1wc8pmMn0xmU2S99QYtGbwT5nu4nimL-xxR-EktVsw3iTAygGrU86B3Wpsx72wEUlK16txce7OoDvou6p09m24NuSgShU3nWu8T0KZ3JRk8MtekeXq7NB24Wufu_F6vru9ml3jzT7Iy2z7shRPD48inYj1upG_iv4AoA3ZIY</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Crystalline forms of (9r, 135s)-13- {4-[5-chloro-2-(4-chloro-1h,2,3- triazol- 1 -yl)phenyl] -6-oxo- 1,6-dihydropyrimidin- 1-yl}-3-(difluoromethyl)-9-methyl-3,4,7,15- tetraazatricyclo [ 12.3.1.02·6] octadeca- 1(18), 2(6), 4, 14, 16-pentaen-8-one</title><source>esp@cenet</source><creator>XIOURAS Christos ; SMITH Daniel ; GALELLA Michael A ; DILGER Andrew K ; L?DEKER David ; ZIEMBA Theresa M ; AHUJA Dipali ; CLEEREN Dirk Angelina J</creator><creatorcontrib>XIOURAS Christos ; SMITH Daniel ; GALELLA Michael A ; DILGER Andrew K ; L?DEKER David ; ZIEMBA Theresa M ; AHUJA Dipali ; CLEEREN Dirk Angelina J</creatorcontrib><description>Disclosed are crystalline forms of Compound (I). Compound (I) is useful as an anti-thromboembolic agent in the treatment of cardiovascular diseases.</description><language>eng ; heb</language><creationdate>2022</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20221201&amp;DB=EPODOC&amp;CC=IL&amp;NR=297206A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20221201&amp;DB=EPODOC&amp;CC=IL&amp;NR=297206A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>XIOURAS Christos</creatorcontrib><creatorcontrib>SMITH Daniel</creatorcontrib><creatorcontrib>GALELLA Michael A</creatorcontrib><creatorcontrib>DILGER Andrew K</creatorcontrib><creatorcontrib>L?DEKER David</creatorcontrib><creatorcontrib>ZIEMBA Theresa M</creatorcontrib><creatorcontrib>AHUJA Dipali</creatorcontrib><creatorcontrib>CLEEREN Dirk Angelina J</creatorcontrib><title>Crystalline forms of (9r, 135s)-13- {4-[5-chloro-2-(4-chloro-1h,2,3- triazol- 1 -yl)phenyl] -6-oxo- 1,6-dihydropyrimidin- 1-yl}-3-(difluoromethyl)-9-methyl-3,4,7,15- tetraazatricyclo [ 12.3.1.02·6] octadeca- 1(18), 2(6), 4, 14, 16-pentaen-8-one</title><description>Disclosed are crystalline forms of Compound (I). Compound (I) is useful as an anti-thromboembolic agent in the treatment of cardiovascular diseases.</description><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2022</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqFT8FKxDAQ3YsHUX9B5thCpmySNrs9yqIoePS2LEtopzSQJiWNYFb8Lu_-k3cj6tnDzDweb97jna8-dyEtUVtrHMHgw7SAH6BoAwMum6VELhFea9w32I3WB48Ci_oP85EJlgUxGH3yFoEDJlvOI7lkD4AK_YvPLFPYmzH1wc8pmMn0xmU2S99QYtGbwT5nu4nimL-xxR-EktVsw3iTAygGrU86B3Wpsx72wEUlK16txce7OoDvou6p09m24NuSgShU3nWu8T0KZ3JRk8MtekeXq7NB24Wufu_F6vru9ml3jzT7Iy2z7shRPD48inYj1upG_iv4AoA3ZIY</recordid><startdate>20221201</startdate><enddate>20221201</enddate><creator>XIOURAS Christos</creator><creator>SMITH Daniel</creator><creator>GALELLA Michael A</creator><creator>DILGER Andrew K</creator><creator>L?DEKER David</creator><creator>ZIEMBA Theresa M</creator><creator>AHUJA Dipali</creator><creator>CLEEREN Dirk Angelina J</creator><scope>EVB</scope></search><sort><creationdate>20221201</creationdate><title>Crystalline forms of (9r, 135s)-13- {4-[5-chloro-2-(4-chloro-1h,2,3- triazol- 1 -yl)phenyl] -6-oxo- 1,6-dihydropyrimidin- 1-yl}-3-(difluoromethyl)-9-methyl-3,4,7,15- tetraazatricyclo [ 12.3.1.02·6] octadeca- 1(18), 2(6), 4, 14, 16-pentaen-8-one</title><author>XIOURAS Christos ; SMITH Daniel ; GALELLA Michael A ; DILGER Andrew K ; L?DEKER David ; ZIEMBA Theresa M ; AHUJA Dipali ; CLEEREN Dirk Angelina J</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_IL297206A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; heb</language><creationdate>2022</creationdate><toplevel>online_resources</toplevel><creatorcontrib>XIOURAS Christos</creatorcontrib><creatorcontrib>SMITH Daniel</creatorcontrib><creatorcontrib>GALELLA Michael A</creatorcontrib><creatorcontrib>DILGER Andrew K</creatorcontrib><creatorcontrib>L?DEKER David</creatorcontrib><creatorcontrib>ZIEMBA Theresa M</creatorcontrib><creatorcontrib>AHUJA Dipali</creatorcontrib><creatorcontrib>CLEEREN Dirk Angelina J</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>XIOURAS Christos</au><au>SMITH Daniel</au><au>GALELLA Michael A</au><au>DILGER Andrew K</au><au>L?DEKER David</au><au>ZIEMBA Theresa M</au><au>AHUJA Dipali</au><au>CLEEREN Dirk Angelina J</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Crystalline forms of (9r, 135s)-13- {4-[5-chloro-2-(4-chloro-1h,2,3- triazol- 1 -yl)phenyl] -6-oxo- 1,6-dihydropyrimidin- 1-yl}-3-(difluoromethyl)-9-methyl-3,4,7,15- tetraazatricyclo [ 12.3.1.02·6] octadeca- 1(18), 2(6), 4, 14, 16-pentaen-8-one</title><date>2022-12-01</date><risdate>2022</risdate><abstract>Disclosed are crystalline forms of Compound (I). Compound (I) is useful as an anti-thromboembolic agent in the treatment of cardiovascular diseases.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng ; heb
recordid cdi_epo_espacenet_IL297206A
source esp@cenet
title Crystalline forms of (9r, 135s)-13- {4-[5-chloro-2-(4-chloro-1h,2,3- triazol- 1 -yl)phenyl] -6-oxo- 1,6-dihydropyrimidin- 1-yl}-3-(difluoromethyl)-9-methyl-3,4,7,15- tetraazatricyclo [ 12.3.1.02·6] octadeca- 1(18), 2(6), 4, 14, 16-pentaen-8-one
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-30T23%3A50%3A55IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=XIOURAS%20Christos&rft.date=2022-12-01&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EIL297206A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true